StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Sigyn Therapeutics's operating margin for the twelve months ending Sep 30, 2020 was -7019.1%. For fiscal 2019 it was -361.4%, against -3544.2% the year before. The highest annual figure on record is -361.4% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 2019-361.4%+3182.8
FY2018Dec 31, 2018-3544.2%+1733.2
FY2017Dec 31, 2017-5277.4%+2436.9
FY2015Dec 31, 2015-7714.3%−6816.3
FY2014Dec 31, 2014-898.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 2020-5294.1%−5136.6
Q1 FY2020Mar 31, 2020-25526.3%−25120.0
Q4 FY2019Dec 31, 2019-2342.4%−2075.6
Q3 FY2019Sep 30, 2019-382.3%+3657.3
Q2 FY2019Jun 30, 2019-157.5%+1087.6
Q1 FY2019Mar 31, 2019-406.4%−179.7
Q3 FY2018Sep 30, 2018-266.8%−124.5
Q2 FY2018Jun 30, 2018-4039.6%−3911.6
Q1 FY2018Mar 31, 2018-1245.1%–
Q3 FY2017Sep 30, 2017-226.7%–
Q2 FY2017Jun 30, 2017-142.3%–
Q1 FY2017Mar 31, 2017-128.0%–

More Sigyn Therapeutics figures

See a number that looks wrong?